Page 18 - Stagezero Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

StageZero Life Sciences Ltd: StageZero Life Sciences to Offer COVID-19 Saliva Test Kits Throughout Canada TORONTO, ON / ACCESSWIRE / May 5, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company"), a specialist in PCR testing dedicated to the early detection of multiple diseases through whole blood, today announced it will distribute via its partner Ichor Blood Services through a Canadian retail outlet, COVID-19 PCR saliva test kits in British Columbia, Alberta, Saskatchewan, Manitoba and Ontario beginning May 5. "StageZero is proud to make these kits available to Canadi...

Press release content from Accesswire. The AP news staff was not involved in its creation. StageZero Life Sciences to Offer COVID-19 Saliva Test Kits Throughout Canada May 5, 2021 GMT TORONTO, ON / ACCESSWIRE / May 5, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company"), a specialist in PCR testing dedicated to the early detection of multiple diseases through whole blood, today announced it will distribute ... TORONTO, ON / ACCESSWIRE / May 5, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company"), a specialist in PCR testing dedicated to the ...

(0) TORONTO, ON / ACCESSWIRE / April 19, 2021 / StageZero Life Sciences (TSX:SZLS), a company dedicated to early detection of multiple disease states through whole blood, today announced that it will be presenting at the Planet MicroCap Showcase: VIRTUAL on Thursday April 22 at 8:30 AM EST. James Howard-Tripp, Chairman and CEO of StageZero will be hosting the presentation and answering questions from investors. To access the live presentation, please use the following information: Planet MicroCap Showcase: VIRTUAL 2021 Date: Thursday, April 22, 2021 Time: 8:30AM Eastern Time (5:30 AM Pacific ...

Share this article Share this article ResearchAndMarkets.com's offering. The scope of the report includes liquid biopsy technologies, applications, industry subsegments, biomarker technologies, major funding initiatives, patents and companies. The market sizes for liquid biopsy diagnostics are given for 2019, 2020 and 2025 (forecasted). Liquid biopsy is creating a paradigm shift in medicine, and this is opening significant market opportunities. These market segments are particularly promising for the following liquid biopsy applications: noninvasive prenatal screening for average-risk populat...

StageZero Life Sciences Ltd: StageZero Life Sciences Announces Signed Letter of Intent for the Acquisition of Health Clinics Limited TORONTO, ON / ACCESSWIRE / April 1, 2021 / StageZero Life Sciences, Ltd (TSX:SZLS) (" StageZero" or the " Company") is pleased to announce that effective March 31, 2021 is has entered into a letter of intent to purchase substantially all of the business of Health Clinics Limited and of Health Clinics USA Corp. (together, the "HC Companies") related to their current oncology business and expanding focus into early disease detection utilizing proprietary treatment...